A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients
Lu, F; Zhou, Q; Liu, L; Zeng, GD; Ci, WM; Liu, WT; Zhang, G; Zhang, ZY; Wang, P; Zhang, AQ; Gao, YF; Yu, L; He, QY; Chen, L
Zhou, Q; He, QY; Chen, L (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res Guangdong Higher Educ, Guangzhou 510632, Guangdong, Peoples R China.; Yu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China.; Gao, YF (corresponding author), Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Guangzhou 510632, Guangdong, Peoples R China.; Gao, YF (corresponding author), Jinan Univ, Sch Pharm, Guangzhou 510632, Guangdong, Peoples R China.
THERANOSTICS, 2020; 10 (2): 484
